Botanix Pharmaceuticals Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:BOTHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (14.84%)
Div yield —
ROE (96.35%)
Biotechnology
Beta (5Y) 0.92
PE TTM —
TSR TTM (92.59%)
Mkt cap A$27.63M
ROIC (58.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0118
17.57%
(43.90%)
Hold 1|3|6|8|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
22.90%
30.35%
35.50%
19.13%
Revenue$M
1.407
1.443
1.525
1.597
9.18%
11.52%
17.11%
19.02%
Peers (US$18.97M)
Cap (US$)
PE
22.69M
—
21.26M
—
Capital
TTM
5Y
10Y
Leveragex
0.402
0.092
0.088
EBIT/Intx
1.088
0.368
0.330
Own earn%
233.09
(108.45)
(106.56)
Sh yield%
33.04
35.14
34.61
Owners
Insiders/Inst%
7.67
53.90
Short interest%
2.68
SBC / revenue%
0.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
25–32
$1 testx
0.0
Incr. ROIC%
10